Early molecular events in the development of the diabetic cardiomyopathy |
| |
Authors: | Mönkemann H De Vriese A S Blom H J Kluijtmans L A J Heil S G Schild H H Golubnitschaja O |
| |
Affiliation: | (1) Department of Radiology, University of Bonn, Germany, DE;(2) Renal Unit, Department of Internal Medicine, University Hospital, Gent, Belgium, BE;(3) Department of Paediatrics and Neurology, University Medical Center Nijmegen, The Netherlands, NL |
| |
Abstract: | Summary. Oxidative damage to DNA has been well documented in cardiac cells isolated from diabetic patients and rats with streptozotocin-induced diabetes mellitus (DM). This study evaluates possible molecular mechanisms for early events in the development of DM-induced cardiomyopathy. Methods: To analyze the mechanism of overexpression of p21WAF1/CIP1 and inhibition of cyclin D1 expression in cardiomyocytes of diabetic rats we examined the methylation status of these genes by MS-PCR and assessed the possibility of epigenetic control of their expression. Results: We found that the steady-state expression of both genes is influenced by their methylation status, as an epigenetic event, of their 5′-flanking regions upon development of diabetes. Conclusions: Oxidative damage contributes to the development of cardiomyopathy via p53-dependent activation of cardiac cell death. This pathway includes de novo methylation of the P53-inducible p21WAF1/CIP1-gene encoding a protein which binds to and inhibits a broad range of cyclin-cyclin-dependent kinase complexes. Received June 29, 2001 Accepted August 6, 2001 Published online August 9, 2002 |
| |
Keywords: | : Diabetes mellitus Cardiomyopathy p21WAF1/CIP1 Cyclin D1 CpG Methylation Gene regulation |
本文献已被 PubMed SpringerLink 等数据库收录! |
|